MAFS stars Jacqui Burfoot and Ryan Donnelly have taken out legal action against each other. Here, a lawyer breaks down what ...
Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock ...
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 ...
New Drug Application (NDA) for LNZ100 for treatment ... today reported financial results for the fourth quarter and full year ended December 31, 2024, and recent corporate highlights. “This year has ...
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 RESTORE-ALS tr ...
New England Conservatory Prep School Celebrates 75 Years with Performances, Special Events, and More
New England Conservatory's Preparatory School has announced the launch of its 75th anniversary celebration—a yearlong series ...
As of December 31, 2024, Fortress' consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as of September 30, 2024, and $80.9 million as of December 31, 2023, a ...
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
FDA Approval of Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended De ...
Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsAdanna Alexander – IRPhillip Chan - ...
Revenues Increased by 51%, Gross Profit Increased by 82% and Net Loss Reduced by 54% for the Year Ended December 31, 2024Rehovot, Israel, March ...
Flat V2O5 prices, China expands VRFB production, AMG finishes Nuremberg plant, and Richmond Vanadium advances mining lease ...
BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results